arrow
H

Hong Wang

national and local joint engineering research center of biodiagnosis and biotherapy
H指数:97
被引数:4.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab and Cabozantinib in People with HIV and Advanced Solid Tumors: A Pilot Trial and Systematic Review

纳武利尤单抗和卡博替尼在HIV感染者及晚期实体瘤患者中的应用:一项初步试验和系统综述

2026-10-080
OA
Potent Liver-Tropic mRNA Lipid Nanoparticles: ApoE-Mediated Delivery Through a Low-Density Lipoprotein Receptor Independent Uptake Mechanism (Adv. Mater. 22/2026)

强效肝靶向mRNA脂质纳米颗粒:通过低密度脂蛋白受体独立摄取机制介导的ApoE介导递送

2026-04-170
OAAI
Biomarker analysis from a Phase 1/1b study of tusamitamab ravtansine in patients with advanced non-small cell lung cancer

tusamitamab ravtansine 在晚期非小细胞肺癌患者中的 Phase 1/1b 研究的生物标志物分析

2025-12-030
OAAI
Broad-Spectrum Peptidomimetic Inhibitors of Norovirus and Coronavirus 3C-like Proteases
2025-12-010
PRE
Potent Liver-Tropic mRNA Lipid Nanoparticles: ApoE-Mediated Delivery Through a Low-Density Lipoprotein Receptor Independent Uptake Mechanism

强效肝靶向mRNA脂质纳米颗粒:通过低密度脂蛋白受体独立摄取机制介导的ApoE递送

2025-11-010
OAAI
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313)

伯佐塞替、卡铂、吉西他滨和帕博利珠单抗在鳞状非小细胞肺癌患者中的 Ib 期研究 (ETCTN 10313)

2025-11-010
OAAI
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

Nguyen, M.K.; Jelinek, M.; Singh, A.; Isett, B.; Myers, E.S.; Mullett, S.J.; Eisele, Y.; Beumer, J.; Parise, R.; Urban, J.; et al. 关于ivosidenib联合nivolumab治疗携带IDH1突变的晚期实体瘤的临床与转化研究。medRxiv 2025. [Google Scholar] [CrossRef]

2025-11-010
PRE